Marinus Pharmaceuticals Inc. Investors: Class action lawsuit filed on behalf of investors; the Portnoy Law Firm LOS ANGELES, July 25, 2024 (GLOBE NEWSWIRE) -- Investors can contact the law firm at no cost to learn more about recovering their losses The Portnoy Law Firm advises Marinus Pharmaceuticals, Inc....

Marinus Pharmaceuticals Inc. Investors: Class action lawsuit filed on behalf of investors; the Portnoy Law Firm Investors can contact the law firm at no cost to learn more about recovering their losses LOS ANGELES, June 28, 2024 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises Marinus Pharmaceuticals, Inc....

MRNS Class Action Alert: Robbins LLP Reminds MRNS Stockholders About the Marinus Pharmaceuticals, Inc. Securities Fraud Class Action Robbins LLP is Investigating Allegations Marinus Pharmaceuticals, Inc. (MRNS) Misled Investors Regarding the Viability of its Drug Candidate

MRNS Class Action Alert: Robbins LLP Reminds Stockholders of the Lead Plaintiff Deadline in the Class Action Against Marinus Pharmaceuticals, Inc. Robbins LLP is Investigating Allegations Marinus Pharmaceuticals, Inc. (MRNS) Misled Investors Regarding the Viability of its Drug Candidate

Stockholder Alert: Robbins LLP Informs Investors that a Shareholder Has Filed a Class Action Against Marinus Pharmaceuticals, Inc. (MRNS) Robbins LLP is Investigating Allegations that Marinus Pharmaceuticals, Inc. (MRNS) Misled Investors Regarding the Viability of its Drug Candidate